Fluid And Imaging Biomarkers in Neuroscience Hilton Boston Back Bay, Boston
The First Industry Forum for Translational Experts, Neuroscience Drug Sponsors and Biomarker Technology Developers to Transform Earlier Assessment of AD, PD, ALS and MS
Development and integration of validated, inexpensive, non-invasive, and reliable fluid and imaging biomarkers are critical to advance neurodegenerative and neuro-immunological drug candidates through clinical trials.
Built to provide cutting-edge insights across emerging biomarker technologies and address the current translational bottleneck hindering your pipeline’s success: the inaugural Fluid and Imaging Biomarkers in Neuroscience Summit is an unrivaled new opportunity to evaluate the latest biomarker research across AD, PD, MS and ALS, in one highly focused forum.
Unite with translational experts and biomarker specialists from the likes of Biogen, Eli Lilly, and Janssen to engage in forward-thinking discussions to meaningfully advance biomarker assessments of neurodegenerative and neuroinflammatory disease-modifying therapeutics.
⌛ Event Dates & Venue
👨👧👦 Social Networks
💸 Website & Tickets
Go to Event Website Drug Developer Pricing | Conference + 2 Workshops: USD 3597.00, Drug Developer Pricing | Conference + 1 Workshop: USD 3098.00, Drug Developer Pricing | Conference Only: USD 2599.00, Solution Providers | Conference + 2 Workshops: USD 5297.00, Solution Providers | Conference + 1 Workshop: USD 4548.00, Solution Providers | Conference Only: USD 3799.00
Advertisements
Similar events
13th Annual Clinical Trials Summit 2022 10th World Congress on Pathology & Cancer Epidemiology 
3rd Genetic Vaccine Development for Infectious Diseases Summit Cell Therapy Analytics: Overcoming CMC Challenges 30th International Biodetection Technologies: Advanced Technologies & Methods for Global Health & Biodefense 
Optimizing AAV Safety Summit